These companies sell peptides labeled for research purposes only or not for human consumption. Quality varies significantly between suppliers, making vendor selection critical
Exenatide extended-release (Bydureon) injectable suspension [package insert]
Some of the drugs for obesity treatment in the early and late stages of development include Semaglutide oral (Novo Nordisk), Tirzepatide (Eli Lilly and Company), Tesomet (Saniona), RZL-012 (Raziel Therapeutics), EMP16 (Empros Pharma), DD01 (D&D Pharmatech), ZP 8396 (Zealand Pharma), ERX-1000 (ERX Pharmaceuticals), Survodutide (Zealand Pharma), Ecnoglutide (Sciwind Biosciences), CT-868 (Carmot Therapeutics), DD01 (D&D Pharmatech), and others
If this broader healthy-aging and recovery conversation feels relevant, the Healthy Aging collection is worth a look